Fried Frank acted as counsel to Citigroup Global Markets as financial advisor to Corindus Vascular Robotics in its US$1.1 billion definitive agreement to be acquired by Siemens Healthineers AG. Corindus is a developer of precision vascular robotics. Siemens Medical Solutions, a medical technology company and a wholly-owned subsidiary of Siemens Healthineers AG, will acquire all issued and outstanding shares of common stock of Corindus. The transaction is expected to close in the fourth quarter of 2019.
The Fried Frank team was led by corporate partner Philip Richter and included corporate associate Roy Tannenbaum.